CCR2 and chronic kidney disease: The results showed that CKD could lead to increased inorganic sulfate level and the consequently enhanced tyrosine sulfation of specific adhesion molecules and chemokine receptors, including CCR2 and CCR5, which might be associated with monocyte/macrophage activation and promoted CKD-related atherosclerosis (Fig. 7).